I am guessing you didn't listen to Ian Dixon's video update yesterday re the objectives of each trial were, because if you did you would realise what uninformed garbage you wrote here.
- Forums
- ASX - By Stock
- Ann: Preclinical Data from Osteoarthritis Animal Study
I am guessing you didn't listen to Ian Dixon's video...
Featured News
Add TYP (ASX) to my watchlist
|
|||||
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $20.69M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 1.9¢ | $36.63K | 1.832M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 532511 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 400000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 532511 | 0.019 |
3 | 252509 | 0.018 |
2 | 775000 | 0.017 |
2 | 978231 | 0.016 |
3 | 2240000 | 0.015 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 400000 | 1 |
0.021 | 514000 | 2 |
0.022 | 302000 | 3 |
0.023 | 750000 | 2 |
0.024 | 840529 | 4 |
Last trade - 15.25pm 15/08/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online